Targeting CD36-Mediated Inflammation Reduces Acute Brain Injury in Transient, but not Permanent, Ischemic Stroke.

CONCLUSION: The study revealed that targeting CD36 has a beneficial effect on transient but not permanent focal ischemic stroke. The study thus precludes a generalized strategy targeting CD36 in ischemic stroke and suggests careful consideration of types of stroke and associated pathology in developing stroke therapies. PMID: 25216018 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25216018?dopt=Abstract

Source: CNS Neuroscience and Therapeutics - September 12, 2014 Category: Neuroscience Authors: Kim E, Tolhurst AT, Szeto HH, Cho S Tags: CNS Neurosci Ther Source Type: research